Growth Opportunities in Single Cell Genomics and Proteomics in the United States

Description

Public Funding and Large Biopharma Investments Support Technological Advancements and Improved Analysis

In recent years, single-cell analysis has changed rapidly. It began as a niche, specialized technology with few companies offering solutions, which then became commonly used in academia. Subsequently, its use has spread to areas such as biopharma, with more companies investing in the research and development (R&D) of single-cell analysis projects.

Globally, the single-cell genomics and proteomics market is growing at high rates. The United States represents about 60% of the total market and is on track to increase about 12% to 16% annually. Much of that growth is characterized by public funding, such as funding by the National Institutes of Health (NIH) and increasing biopharma investments. Greater adoption and better handling of artificial intelligence (AI) and machine learning (ML) tools will drive this market's growth. These novel tools encourage the development of software and data analysis solutions to help researchers interpret data.

This report examines the US single-cell genomics and proteomics market and provides a forecast from 2023 to 2028. It assesses the market for single-cell analysis tools used for analytical and isolation purposes across workflows, technologies, and applications. Frost & Sullivan provides information on market concentration and evolution, leading providers, application areas, and technologies. This study will help vendors understand critical trends emerging for various application domains.

Product Code: K998-55

Strategic Imperatives

Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the US Single-cell Genomics and Proteomics Industry
Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

Scope of Analysis
Segmentation
Key Competitors by Workflow
Growth Metrics
Growth Drivers
Growth Restraints
Forecast Assumptions
Revenue Forecast
Revenue Forecast Analysis
Revenue Forecast by Workflow
Percent Revenue Forecast by Workflow
Forecast Analysis by Workflow
Revenue Forecast by Application
Percent Revenue Forecast by Application
Forecast Analysis by Application
Revenue Forecast by Technology
Percent Revenue Forecast by Technology
Forecast Analysis by Technology
Pricing Trends and Forecast Analysis
Competitive Environment
Revenue Share
Revenue Share Analysis
Key Companies to Watch
Company Solutions
Key Technologies and Workflow-Competitor Landscape
Interest in Single-cell Genomics
Single-cell Analysis Workflow Technology
Key Partnerships and Collaborations

Funding Trends

Early-stage Company Funding Trends for Single-cell Analysis
Research Center Funding Trends for Single-cell Analysis
Single-cell Genomics and Proteomics Cores around the World

Growth Opportunity Universe

Growth Opportunity 1: Bioinformatics Tools and Platforms for Analyzing and Interpreting Large-scale Single-cell Data
Growth Opportunity 2: Automation and High-throughput Solutions for Tissue Dissociation Processes
Growth Opportunity 3: The Integration of Multi-Omics Data to Drive the Development of Personalized Medicine

Next Steps

Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer